VIVOS INC (RDGL) — SEC Financial Statements & Analysis

VIVOS INC (RDGL) is a surgical & medical instruments & apparatus company, incorporated in DE. VIVOS INC trades on OTC as: RDGL. VIVOS INC (RDGL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, VIVOS INC carries a market cap of $30.04M, a P/E ratio of -8.34x, a P/B ratio of 10.90x, a P/S ratio of 303.09x, an enterprise value of $27.70M, and an EV/EBITDA multiple of -9.83x. On profitability, it posts a gross margin of -25.89%, an operating margin of -2852.46%, a net margin of -3633.58%, a Return on Equity (ROE) of -132.51%, a Return on Assets (ROA) of -127.35%, and a Return on Invested Capital (ROIC) of -1281.64%. Per share, it reports EPS of $-0.01, diluted EPS of $-0.01, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 91.52% year-over-year, net income growth of 8.18% year-over-year, and EPS growth of -0.02% year-over-year. On the balance sheet, it maintains a current ratio of 48.85x, a quick ratio of 47.06x, working capital of $2.39M, a debt-to-equity ratio of 0.04x, a debt ratio of 0.04, an interest coverage ratio of -38.43x, free cash flow of $-2.41M (TTM), and net debt of $-2.34M. Figures sourced from SEC EDGAR.

Market Cap

$30.04M

P/E TTM

-8.34x

EPS TTM

$-0.01

P/B TTM

10.90x

ROE TTM

-132.51%

ROA TTM

-127.35%

Debt To Equity

0.04x

Free Cash Flow TTM

$-2.41M

Net Revenue TTM Growth 1Y

91.52%

Data as of 2026-06-30 · Source: SEC EDGAR